
Penover 37.5mg/325mg Tablet
Marketer
Syncom Formulations I Limited
Salt Composition
Tramadol (37.5mg) + Paracetamol (325mg)
Overview Penover 37.5mg/325mg Tablet
Combiflex 37.5mg/325mg tablets offer dual-action pain relief for moderate to severe discomfort. Dosage and treatment duration for Combiflex should strictly follow your physician's instructions. The medication can be ingested with or without food; however, consuming it with food may alleviate potential stomach upset. Consistent medication intake is crucial; do not discontinue use without consulting your doctor. Potential side effects, including nausea, vomiting, dry mouth, dizziness, and constipation, are generally mild and transient. Report any rashes or allergic reactions promptly. Pregnant individuals, those planning pregnancy, or breastfeeding mothers should seek medical advice prior to using Combiflex.
Uses of Penover 37.5mg/325mg Tablet
Significant to intense pain
Major Benefits of Penover 37.5mg/325mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Penover 37.5mg/325mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Penover 37.5mg/325mg Tablet:
- Nausea
- Vomiting
- Constipation
- Dizziness
- Dryness in mouth
- Sleepiness
- Diarrhea
- Abdominal pain
- Dyspepsia
- Flatulence
- Headache
- Trembling
- Anxiety
- Sleep disorder
- Itching
How to use Penover 37.5mg/325mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Penover 37.5mg/325mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Penover 37.5mg/325mg Tablet works:
Combiflam 37.5mg/325mg tablets offer dual pain relief through the combined action of tramadol and paracetamol. Tramadol, an opioid analgesic, diminishes pain sensation by interrupting pain signals to the brain. Paracetamol, concurrently, reduces pain by inhibiting the production of specific pain-inducing chemical messengers.
SAFETY ADVICE
AlcoholUNSAFE
Combining Penover 37.5mg/325mg Tablet with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Penover 37.5mg/325mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of Penover 37.5mg/325mg tablets appear compatible based on currently available evidence. Studies in humans indicate minimal infant risk. However, seek immediate medical attention should the infant exhibit excessive drowsiness, feeding difficulties, respiratory distress, or hypotonia.
DrivingUNSAFE
Taking Penover 37.5mg/325mg tablets might impair your driving ability due to potential side effects.
KidneyCAUTION
Patients with kidney impairment should exercise caution when taking Penover 37.5mg/325mg tablets. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Penover 37.5mg/325mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Penover 37.5mg/325mg tablets are contraindicated in individuals with severe or active liver disease.
What if you forget to take Penover 37.5mg/325mg Tablet :
Should you forget to take a Penover 37.5mg/325mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Penover 37.5mg/325mg Tablet
| Label | Value |
|---|---|
| Developing Habits | Affirmative. |
| Treatment Category | Pain Relievers |
